GNPX (Genprex, Inc. Common Stock) Stock Analysis - Community
Genprex, Inc. Common Stock (GNPX) is a publicly traded Healthcare sector company. As of May 20, 2026, GNPX trades at $0.79 with a market cap of $8.39M and a P/E ratio of -0.04. GNPX moved -1.47% today. Year to date, GNPX is -56.12%; over the trailing twelve months it is -94.52%. Its 52-week range spans $0.74 to $198.50. Rallies surfaces GNPX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade GNPX?
Rallies community data for GNPX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
LONGNECKER BRENT M sold 8 (~$9.84) on Apr 14, 2026.
LONGNECKER BRENT M sold 10 (~$12.3) on Apr 14, 2026.
Varner John Rodney bought 19.00K (~$20.05K) on Apr 21, 2023.
GNPX Analyst Consensus
GNPX analyst coverage data. Average price target: $0.00.
Common questions about GNPX
How does the Rallies community trade GNPX?
Rallies community data for GNPX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for GNPX?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for GNPX when enough community data is available.
Is GNPX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GNPX. It does not provide personalized investment advice.